Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The HIV Vaccine Trials Network (HVTN) is an international collaboration of scientists and educators searching for an effective and safe HIV vaccine. The HVTN's mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally. Our organization conducts all phases of clinical trials, from evaluating experimental vaccines for safety and the ability to stimulate immune responses, to testing vaccine efficacy.
HIV Diagnostics in the context of vaccine and antibody mediated prevention trials is complex and requires significant oversight and expertise. The HVTN employs four regional laboratories to perform the diagnostics for trials conducted in the U.S., Europe, Africa, and South America. These laboratories utilize the HVTN HIV Algorithm Workflow System (HAWS), which guides the laboratories through the diagnostics algorithms and creates reports for the clinics and independent adjudicators. All data from the HVTN diagnostic laboratories is uploaded to and analyzed by the HVTN Statistical Data Management Center (SDMC). Clinical reports are distributed via a secure web-based system and adjudicated by external reviewers. Diagnostic testing includes multiple different serologic tests as well as assays for HIV RNA and DNA to diagnose HIV infection and identify Vaccine Induced Seropositivity/Seroreactivity (VISP/R) in study participant specimens.
The Diagnostics Project Manager works as part of the HVTN Laboratory Operations team within the HVTN Laboratory Center and reports to the HVTN Director of Laboratory Operations. The incumbent will liaise directly with the Principal Investigators (PIs) and laboratory managers of the four regional HIV diagnostics laboratories for oversight of conduct of viral diagnostic testing, specimen management and data reporting. They will also assist clinical trial sites with questions related to specimen collection or results reporting, identify and manage CROs required for protocol operations, and advise internal and external groups in the regulatory requirements of diagnostic testing and the interpretation of diagnostic/genomic data.
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations.
As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.